Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Scholar Rock Holding

Market Cap: US$2.8b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

Haleon

Market Cap: UK£34.3b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Biohaven

Market Cap: US$1.9b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

GSK

Market Cap: €54.2b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Camp4 Therapeutics

Market Cap: US$32.6m

A clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases.

Celcuity

Market Cap: US$378.0m

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Crinetics Pharmaceuticals

Market Cap: US$2.8b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Actinium Pharmaceuticals

Market Cap: US$37.7m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Vireo Growth

Market Cap: US$190.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Knight Therapeutics

Market Cap: US$566.4m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

Hikma Pharmaceuticals

Market Cap: US$4.2b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Blueprint Medicines

Market Cap: US$5.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Jaguar Health

Market Cap: US$3.8m

A commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea.

Eli Lilly

Market Cap: CA$659.9b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

CordovaCann

Market Cap: CA$9.9m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

10x Genomics

Market Cap: US$918.5m

A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

Viva Biotech Holdings

Market Cap: €2.9b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

scPharmaceuticals

Market Cap: US$128.2m

A pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.

Zai Lab

Market Cap: US$3.2b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

SynBiotic

Market Cap: €21.2m

Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.

MedCap

Market Cap: SEK 5.8b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

HCW Biologics

Market Cap: US$8.6m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

NATCO Pharma

Market Cap: ₹148.2b

A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.

CRISPR Therapeutics

Market Cap: US$3.2b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Telix Pharmaceuticals

Market Cap: AU$8.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States.

Geron

Market Cap: US$789.8m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Ultragenyx Pharmaceutical

Market Cap: R$3.4b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Monopar Therapeutics

Market Cap: €242.0m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Madrigal Pharmaceuticals

Market Cap: US$6.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Bioventix

Market Cap: €133.2m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Enzon Pharmaceuticals

Market Cap: €7.4m

Does not have significant operations.

Cipher Pharmaceuticals

Market Cap: €305.1m

Operates as a specialty pharmaceutical company in Canada.

Blueprint Medicines

Market Cap: US$5.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Daewoong Pharmaceutical

Market Cap: ₩1.5t

Manufactures and sells pharmaceutical products in South Korea and internationally.

Dynavax Technologies

Market Cap: US$1.3b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.